Royalty Pharma
RPRX
#625
Rank
NZ$70.82 B
Marketcap
NZ$123.18
Share price
-1.38%
Change (1 day)
76.66%
Change (1 year)

P/S ratio for Royalty Pharma (RPRX)

P/S ratio as of November 2026 (TTM): 14.9

According to Royalty Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.99. At the end of 2026 the company had a P/S ratio of 12.6.

P/S ratio history for Royalty Pharma from 2020 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202612.632.46%
20259.5343.34%
20246.65-7.06%
20237.15-8.2%
20227.794.23%
20217.48-18.32%
20209.15

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Abbott Laboratories
ABT
3.83-74.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
13.9-6.48%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
1.52-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA